Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$425K Buy
3,901
+267
+7% +$27.1K 0.1% 108
2020
Q2
$332K Buy
3,634
+132
+4% +$11.9K 0.09% 104
2020
Q1
$276K Buy
3,502
+226
+7% +$18.9K 0.08% 113
2019
Q4
$285K Sell
3,276
-24
-0.7% -$2.01K 0.08% 133
2019
Q3
$276K Sell
3,300
-41
-1% -$3.48K 0.08% 122
2019
Q2
$281K Buy
3,341
+41
+1% +$3.23K 0.09% 118
2019
Q1
$264K Buy
3,300
+1
+0% +$74 0.09% 120
2018
Q4
$239K Hold
3,299
0.09% 119
2018
Q3
$242K Buy
+3,299
New +$217K 0.08% 122
2013
Q3
Sell
-10,832
Closed -$373K 70
2013
Q2
$373K Buy
+10,832
New +$397K 0.3% 47

Other funds holding ABT

FCG Advisors's ABT Position: Q3 2020 in Review

FCG Advisors increased its Abbott (ABT) stake by 7.3% in Q3 2020, buying an estimated $27.1K and bringing the position to 3,901 shares worth $425K. The position accounts for 0.1% of the portfolio, ranked #108.

FCG Advisors first reported a position in ABT in Q2 2013 and has held it in 10 quarters since. 2,306 funds tracked by Wall St. Rank hold ABT as of Q3 2020.

  • FCG Advisors held 3,901 shares of Abbott worth $425K as of Q3 2020.
  • FCG Advisors bought 267 Abbott shares in Q3 2020, an estimated $27.1K.
  • Abbott made up 0.1% of FCG Advisors's portfolio in Q3 2020, its #108 holding.
  • FCG Advisors first reported a position in Abbott in Q2 2013 and has held it in 10 quarters since.
  • 2,306 funds tracked by Wall St. Rank held Abbott as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.